Concepedia

Author

Gregory D. Espenan

University Medical Center New Orleans

Also Known As

G D Espenan, G. Espenan, G.D. Espenan, Gregory D. Espenan, Gregory Espenan

19

Publications

738

Citations

10

H-Index

22

Concepts

All Affiliations

University Medical Center New OrleansLouisiana State University Health Sciences Center New OrleansLouisiana State UniversityExcel Diagnostics ImagingThe Ohio State University
GD

About

Gregory D. Espenan is an author at University Medical Center New Orleans specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

354

2

Engineering

1

1

15

3

Natural Sciences

1

1

51

4

Cell Biology

1

1

51

5

Molecular Biology

1

1

51

Gregory D. Espenan

×

12

Publications

720

Citations

10

H-Index

YearCitations

Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies

Lowell Anthony, Eugene A. Woltering, Gregory D. Espenan,

Seminars in Nuclear Medicine

2002

277

Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Patients With Somatostatin Receptor–Expressing Neuroendocrine Tumors

Ebrahim S. Delpassand, Amin Samarghandi, Sara Zamanian,

Pancreas

2014

132

Growing vascular endothelial cells express somatostatin subtype 2 receptors

James C. Watson, Douglas A. Balster, B Gebhardt,

British Journal of Cancer

2001

90

Safety and Efficacy of Radionuclide Therapy with High-Activity In-111 Pentetreotide in Patients with Progressive Neuroendocrine Tumors

Ebrahim S. Delpassand, Jennifer Sims‐Mourtada, Hitomi Saso,

Cancer Biotherapy and Radiopharmaceuticals

2008

52

Progressive nuclear translocation of somatostatin analogs.

Conrad A. Hornick, Catherine T. Anthony, Susan Hughey,

PubMed

2000

51

Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide

Ebrahim S. Delpassand, Amin Samarghandi, Jennifer Sims Mourtada,

Theranostics

2012

33

A Phase I/II Trial of 125I Methylene Blue for One-Stage Sentinel Lymph Node Biopsy

Jason D. Cundiff, Yi‐Zarn Wang, Gregory D. Espenan,

Annals of Surgery

2007

23

Synthesis and characterization of multiply‐tyrosinated, multiply‐iodinated somatostatin analogs

E.A. Woltering, George J. Drouant, Daniel S. Diaco,

Journal of Peptide Research

1999

16

Intraoperative Gamma Detection Of125I-Lanreotide in Women With Primary Breast Cancer

Maria C. Cuntz, Edward A. Levine, Thomas M. O’Dorisio,

Annals of Surgical Oncology

1999

15

Multiply Radioiodinated Somatostatin Analogs Induce Receptor-Specific Cytotoxicity

Michael C. Meyers, Catherine T. Anthony, D.H. Coy,

Journal of Surgical Research

1998

11

Page 1